VISTAGEN THERAPEUTICS, INC. Public Float
VISTAGEN THERAPEUTICS, INC. (VTGN) had Public Float of $137.70 million as of 2025-09-30, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-15
- 2025-09-30: Entity Public Float $137.70M.
- 2024-09-30: Entity Public Float $81.20M.
- 2023-09-30: Entity Public Float $62.70M.
- 2022-09-30: Entity Public Float $31.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-09-30 | $137.70M 10-K · filed 2026-06-15 |
| 2024-09-30 | $81.20M 10-K · filed 2025-06-17 |
| 2023-09-30 | $62.70M 10-K · filed 2024-06-11 |
| 2022-09-30 | $31.20M 10-K · filed 2023-06-28 |
| 2021-09-30 | $536.81M 10-K · filed 2022-06-23 |
| 2020-09-30 | $51.37M 10-K · filed 2021-06-29 |
| 2019-09-30 | $45.35M 10-K · filed 2020-06-29 |
| 2018-09-30 | $41.11M 10-K · filed 2019-06-25 |
| 2017-09-30 | $18.31M 10-K · filed 2018-06-26 |
| 2016-09-30 | $34.03M 10-K · filed 2017-06-29 |
| 2015-09-30 | $13.69M 10-K · filed 2016-06-24 |
| 2014-09-30 | $10.08M 10-K · filed 2015-06-29 |
| 2014-08-08 | $9.66M 10-Q · filed 2014-08-12 |
| 2014-06-19 | $9.66M 10-K · filed 2014-06-25 |
| 2014-02-10 | $9.66M 10-Q · filed 2014-02-14 |
| 2013-11-12 | $9.66M 10-Q · filed 2013-11-14 |
| 2013-08-12 | $8.32M 10-Q · filed 2013-08-14 |
| 2013-07-12 | $8.32M 10-K · filed 2013-07-18 |
| 2013-02-12 | $8.32M 10-Q · filed 2013-02-14 |
| 2012-11-12 | $8.32M 10-Q · filed 2012-11-14 |
| 2012-08-13 | $22.21M 10-Q · filed 2012-08-14 |
| 2012-06-28 | $22.21M 10-K · filed 2012-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |